Heron Therapeutics | HRTX - Stock


Heron Therapeutics reported $54.57M in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
ALKERMES USD 298.96M 37.75M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Amarin USD 164.07M 19.51M Jun/2026
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Eisai JPY 257.55B 21.09B Mar/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
Merck USD 6.21B 272M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Omeros USD 712K 266K Sep/2021
Pacira USD 134.57M 15.8M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Veracyte USD 22.66M 1.24M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026